Next Article in Journal
ABL001, a Bispecific Antibody Targeting VEGF and DLL4, with Chemotherapy, Synergistically Inhibits Tumor Progression in Xenograft Models
Next Article in Special Issue
Creation of New Antimicrobial Peptides
Previous Article in Journal
Current Trends and Future Prospects of Molecular Targeted Therapy in Head and Neck Squamous Cell Carcinoma
Previous Article in Special Issue
Lipidation of Antimicrobial Peptides as a Design Strategy for Future Alternatives to Antibiotics
 
 
Article

Article Versions Notes

Int. J. Mol. Sci. 2021, 22(1), 242; https://doi.org/10.3390/ijms22010242
Action Date Notes Link
article xml file uploaded 29 December 2020 07:17 CET Original file -
article xml uploaded. 29 December 2020 07:17 CET Update https://www.mdpi.com/1422-0067/22/1/242/xml
article pdf uploaded. 29 December 2020 07:17 CET Version of Record https://www.mdpi.com/1422-0067/22/1/242/pdf
article supplementary file uploaded. 29 December 2020 07:17 CET - https://www.mdpi.com/1422-0067/22/1/242#supplementary
article html file updated 29 December 2020 07:18 CET Original file -
article html file updated 23 July 2022 08:04 CEST Update https://www.mdpi.com/1422-0067/22/1/242/html
Back to TopTop